BidaskClub downgraded shares of Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) from a hold rating to a sell rating in a research note released on Saturday, BidAskClub reports.

Separately, Zacks Investment Research cut shares of Neptune Wellness Solutions from a hold rating to a sell rating in a research note on Friday, June 12th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of Hold and an average target price of $4.63.

Shares of Neptune Wellness Solutions stock opened at $2.93 on Friday. The stock has a market cap of $301.66 million, a price-to-earnings ratio of -5.98 and a beta of 2.72. The firm’s 50-day moving average is $2.79 and its 200 day moving average is $2.28. Neptune Wellness Solutions has a 1 year low of $0.96 and a 1 year high of $6.57. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.25 and a quick ratio of 1.73.

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) last announced its quarterly earnings results on Wednesday, June 10th. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.08) by ($0.13). The firm had revenue of $7.11 million during the quarter, compared to the consensus estimate of $6.32 million. Neptune Wellness Solutions had a negative return on equity of 51.03% and a negative net margin of 204.83%. On average, equities analysts expect that Neptune Wellness Solutions will post -0.13 EPS for the current fiscal year.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. AdvisorShares Investments LLC lifted its stake in Neptune Wellness Solutions by 9.2% during the 1st quarter. AdvisorShares Investments LLC now owns 395,607 shares of the biotechnology company’s stock valued at $463,000 after acquiring an additional 33,426 shares during the period. Essex Investment Management Co. LLC bought a new position in Neptune Wellness Solutions during the 4th quarter valued at about $663,000. Deutsche Bank AG lifted its stake in Neptune Wellness Solutions by 333.2% during the 1st quarter. Deutsche Bank AG now owns 231,664 shares of the biotechnology company’s stock valued at $271,000 after acquiring an additional 178,192 shares during the period. White Pine Capital LLC lifted its stake in Neptune Wellness Solutions by 55.7% during the 1st quarter. White Pine Capital LLC now owns 117,932 shares of the biotechnology company’s stock valued at $138,000 after acquiring an additional 42,200 shares during the period. Finally, Oxford Asset Management LLP purchased a new stake in shares of Neptune Wellness Solutions during the 4th quarter valued at about $277,000. Institutional investors and hedge funds own 16.85% of the company’s stock.

Neptune Wellness Solutions Company Profile

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Featured Article: How Investors Can Profit from Options Trading

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.